Journal
PLACENTA
Volume 27, Issue 2-3, Pages 191-199Publisher
W B SAUNDERS CO LTD
DOI: 10.1016/j.placenta.2005.01.012
Keywords
placenta; trophoblast; p38; PPAR gamma; p38 inhibitor
Funding
- NICHD NIH HHS [HD-29190, K12 HD-01459] Funding Source: Medline
- NIEHS NIH HHS [ES-11597] Funding Source: Medline
Ask authors/readers for more resources
Deficiency of either the mitogen-activated protein kinase p38 or the nuclear receptor PPAR gamma results in disrupted vasculogenesis and abnormal development of the murine placenta. In addition, PPAR gamma regulates differentiation of human trophoblasts. Here we tested the hypothesis that p38 plays an important role in the regulation of PPAR gamma in primary human trophoblasts. We initially confirmed that cultured trophoblasts derived from normal term human placentas express p38 as well as its functional phosphorylated form. Whereas PPAR gamma did not alter p38 expression, p38 inhibitors diminished the transcriptional activity of PPAR gamma in primary trophoblasts. In addition, inhibition of p38 resulted in marked attenuation of PPAR gamma-stimulated hCG production by cultured trophoblast. Our data support an effect of p38 on PPAR gamma protein stability because p38 inhibition led to reduced expression of PPAR gamma protein without a significant effect on PPAR gamma mRNA, and this reduction was blocked by the protease inhibitor MG-132. Together, these data indicate that p38 regulates PPAR gamma expression and activity in term human trophoblasts. Cross talk between p38 and PPAR gamma signaling may play a role in modulating differentiation and function of the human placenta. (c) 2005 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available